$13.24
0.514.01%
近くで: Nov 13, 4:00 PM EST
$13.15
-0.09-0.68%
時間外: 5:41 PM EST
Benzinga
Benzinga
Benzinga
土曜日, 11 14
Benzinga
© 2026 Benzinga | All Rights Reserved
Usana Health Sciences fell 31.0% from $19.19 to $13.24, behind the S&P 500's +12.3%. Its worst day was Aug 5 (−34.2%), and its low came Nov 12 at $12.73.
Nov 14, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.60 beat the $0.41 estimate on $226.2M revenue (est. $226.0M); FY revenue guidance of $925.0M–$1.0B against the $943.7M consensus.
−8.0% · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
EPS of $0.61 beat the $0.44 estimate on $250.2M revenue (est. $241.0M); FY revenue guidance of $925.0M–$1.0B against the $938.7M consensus.
+3.9% · S&P 500 +1.4%
Usana Health Sciences closed at its highest level of the year, 21.1% above where the year started.
+4.0% · S&P 500 +0.2%
EPS of $-0.07 missed the $0.43 estimate on $223.3M revenue (est. $235.0M); FY revenue guidance of $910.0M against the $945.1M consensus.
−34.2%, the year's worst day, on 689K shares, the year's heaviest volume · S&P 500 −0.2%
EPS of $-0.11 missed the $0.11 estimate on $205.9M revenue (est. $217.4M); FY revenue guidance of $900.0M against the $909.0M consensus.
−3.6% · S&P 500 +1.7%
Where it ended: a close of $13.24 on Nov 13, 2026. Up next: Q4 2026 earnings on Feb 16, 2027 (EPS est. $0.12, revenue est. $219.7M).
Nothing in the past 12 months.
All USNA analyst actionsNothing in the past 12 months.
All USNA dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for USNA and SPY from Benzinga historical bars. Not investment advice.